Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209–249 (2021).

Article  PubMed  Google Scholar 

Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394–424 (2018).

Article  PubMed  Google Scholar 

Siegel, R. L., Miller, K. D., Fuchs, H. E. & Jemal, A. Cancer statistics, 2022. CA Cancer J. Clin. 72, 7–33 (2022).

Article  PubMed  Google Scholar 

Board, W. C. O. T. E. Urinary and Male Genital Tumours. 5th edn, (International Agency for Research on Cancer, 2022).

Kamat, A. M. et al. Bladder cancer. Lancet 388, 2796–2810 (2016).

Article  PubMed  Google Scholar 

Hedegaard, J. et al. Comprehensive transcriptional analysis of early-stage urothelial carcinoma. Cancer Cell 30, 27–42 (2016).

Article  CAS  PubMed  Google Scholar 

Lindgren, D. et al. Combined gene expression and genomic profiling define two intrinsic molecular subtypes of urothelial carcinoma and gene signatures for molecular grading and outcome. Cancer Res. 70, 3463–3472 (2010).

Article  CAS  PubMed  Google Scholar 

Sjodahl, G. et al. A molecular taxonomy for urothelial carcinoma. Clin. Cancer Res. 18, 3377–3386 (2012).

Article  PubMed  Google Scholar 

Sjodahl, G. et al. Toward a molecular pathologic classification of urothelial carcinoma. Am. J. Pathol. 183, 681–691 (2013).

Article  CAS  PubMed  Google Scholar 

Compérat, E. et al. Current best practice for bladder cancer: a narrative review of diagnostics and treatments. Lancet 400, 1712–1721 (2022).

Article  PubMed  Google Scholar 

Choi, W. et al. Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy. Cancer Cell 25, 152–165 (2014).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guo, C. C. et al. Assessment of luminal and basal phenotypes in bladder cancer. Sci. Rep. 10, 9743 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Robertson, A. G. et al. Comprehensive molecular characterization of muscle-invasive bladder cancer. Cell 171, 540–556 e525 (2017).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Damrauer, J. S. et al. Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology. Proc. Natl Acad. Sci. USA 111, 3110–3115 (2014).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kamoun, A. et al. A consensus molecular classification of muscle-invasive bladder cancer. Eur. Urol. 77, 420–433 (2020).

Article  PubMed  Google Scholar 

The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 507, 315–322 (2014).

Article  Google Scholar 

Guo, C. C. & Czerniak, B. Bladder cancer in the genomic era. Arch. Pathol. Lab. Med. 143, 695–704 (2019).

Article  CAS  PubMed  Google Scholar 

Czerniak, B., Dinney, C. & McConkey, D. Origins of bladder cancer. Annu. Rev. Pathol. 11, 149–174 (2016).

Article  CAS  PubMed  Google Scholar 

Spiess, P. E. & Czerniak, B. Dual-track pathway of bladder carcinogenesis: practical implications. Arch. Pathol. Lab. Med. 130, 844–852 (2006).

Article  CAS  PubMed  Google Scholar 

Amin, M. B. Histological variants of urothelial carcinoma: diagnostic, therapeutic and prognostic implications. Mod. Pathol. 22, S96–S118 (2009).

Article  PubMed  Google Scholar 

Al-Ahmadie, H. A. et al. Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer. Nat. Genet. 48, 356–358 (2016).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hoffman-Censits, J. et al. Urothelial cancers with small cell variant histology have confirmed high tumor mutational burden, frequent TP53 and RB mutations, and a unique gene expression profile. Eur. Urol. Oncol. 4, 297–300 (2021).

Article  PubMed  Google Scholar 

Matulay, J. T., Narayan, V. M. & Kamat, A. M. Clinical and genomic considerations for variant histology in bladder cancer. Curr. Oncol. Rep. 21, 23 (2019).

Article  PubMed  Google Scholar 

Monn, M. F. et al. Contemporary bladder cancer: variant histology may be a significant driver of disease. Urol. Oncol. 33, 18.e15–18.e20 (2015).

Article  PubMed  Google Scholar 

Takahara, T., Murase, Y. & Tsuzuki, T. Urothelial carcinoma: variant histology, molecular subtyping, and immunophenotyping significant for treatment outcomes. Pathology 53, 56–66 (2021).

Article  CAS  PubMed  Google Scholar 

Willis, D. L., Porten, S. P. & Kamat, A. M. Should histologic variants alter definitive treatment of bladder cancer? Curr. Opin. Urol. 23, 435–443 (2013).

Article  PubMed  Google Scholar 

Grignon DJ, A.-A. H. et al. Tumors of the Urinary Tract. 4th edn, 77–133 (IARC Press, 2016).

Guo, C. C. & Czerniak, B. Molecular taxonomy and immune checkpoint therapy in bladder cancer. Surg. Pathol. Clin. 15, 681–694 (2022).

Article  PubMed  Google Scholar 

Guo, C. C. et al. Dysregulation of EMT drives the progression to clinically aggressive sarcomatoid bladder cancer. Cell Rep. 27, 1781–1793.e1784 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang, G. et al. Small cell carcinoma of the urinary bladder: a clinicopathologic and immunohistochemical analysis of 81 cases. Hum. Pathol. 79, 57–65 (2018).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moss, T. J. et al. Comprehensive genomic characterization of upper tract urothelial carcinoma. Eur. Urol. 72, 641–649 (2017).

Article  CAS  PubMed  Google Scholar 

Guo, C. C. et al. Gene expression profile of the clinically aggressive micropapillary variant of bladder cancer. Eur. Urol. 70, 611–620 (2016).

Article  CAS  PubMed  PubMed Central  Google Scholar 

McConkey, D. J. et al. A prognostic gene expression signature in the molecular classification of chemotherapy-naive urothelial cancer is predictive of clinical outcomes from neoadjuvant chemotherapy: a phase 2 trial of dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin with bevacizumab in urothelial cancer. Eur. Urol. 69, 855–862 (2016).

Article  CAS  PubMed  Google Scholar 

Dadhania, V. et al. Meta-analysis of the luminal and basal subtypes of bladder cancer and the identification of signature immunohistochemical markers for clinical use. EBioMedicine 12, 105–117 (2016).

Article  PubMed  PubMed Central  Google Scholar 

Weinstein, J. N. et al. The Cancer Genome Atlas pan-cancer analysis project. Nat. Genet. 45, 1113–1120 (2013).

Article  PubMed  PubMed Central  Google Scholar 

Hudson, T. J. et al. International network of cancer genome projects. Nature 464, 993–998 (2010).

Article  CAS  PubMed  Google Scholar 

Navin, N. et al. Tumour evolution inferred by single-cell sequencing. Nature 472, 90–94 (2011).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang, Y. et al. Clonal evolution in breast cancer revealed by single nucleus genome sequencing. Nature 512, 155–160 (2014).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tang, F. et al. mRNA-Seq whole-transcriptome analysis of a single cell. Nat. Methods 6, 377–382 (2009).

Article  CAS  PubMed  Google Scholar 

Williams, C. G., Lee, H. J., Asatsuma, T., Vento-Tormo, R. & Haque, A. An introduction to spatial transcriptomics for biomedical research. Genome Med. 14, 68 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alizadeh, A. A. et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403, 503–511 (2000).